HealthBeacon begins trading in the U.S. on OTCQX Market
Dublin, 31 August 2022: HealthBeacon plc ("HealthBeacon" or the "Company"), the leading digital therapeutics company for managing injectable medications for patients in the home, today commences trading on the OTCQX® Best Market in the U.S. under the ticker symbol 'HBCNF'.
The OTCQX is the top tier of the three marketplaces for the over the counter (OTC) trading of stocks and is operated by the OTC Markets Group. For companies listed on a qualified international exchange, trading on the OTCQX facilitates more efficient access to the U.S. financial markets for HealthBeacon and, through streamlined market standards, enables transparent trading of the Company's stock for U.S. investors.
"We are very pleased to begin trading on the OTCQX market, an important milestone for HealthBeacon that provides an opportunity to grow our U.S. investor base," said HealthBeacon CEO and Co-founder, Jim Joyce. "Fundamentally, this development enables greater awareness and increased visibility of our stock in one of our core markets, but we also believe it will provide improved liquidity and, consequently, enhance shareholder value. The U.S. is a fast-growing market for HealthBeacon as part of our mission to become the world's leading platform for managing injectable medications and we want to continue to build on our success. This is yet another step on our journey, as a listed business, towards connecting people to better health through sustainable, digitally enabled solutions," he said.
To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws.
| Enquiries: |
|
| HealthBeacon: Laurence Flavin
|
Investor.Relations@HealthBeacon.com |
| Goodbody (Euronext Listing Sponsor and Broker): David Kearney |
+353 (1) 667 0420 |
| Stephen Kane |
|
|
Drury (Public Relations): |
|
| Cathal Barry |
+353 (0) 87 227 9281 |
| Paul Clifford |
+353 (0)87 327 2161 |
About HealthBeacon PLC
Headquartered in Dublin, HealthBeacon is an Irish digital therapeutics company that develops products for managing injectable medications for patients in the home. The HealthBeacon Injection Care Management System tracks adherence and persistence with medication schedules through the provision of medication management reminders, safe and sustainable sharps disposal devices, educational tools, and artificial intelligence (AI) driven data analytics. The Company operates across Europe, North America and the United Kingdom and employs more than 70 people and has obtained more than 30 design and utility patents. Peer reviewed evidence supports a 19% improvement in therapy persistence by patients and up to 26% improvement in adherence to therapy, which improves clinical outcomes and significantly improves efficiency in health systems. The Company's mission is to become the world's leading digital therapeutics platform for injectable medications.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX® Best Market, OTCQB® Venture Market and Pink® Open Market.
Our OTC Link® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets.
OTC Link ATS, OTC Link ECN and OTC Link NQB are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.